Ångstrom Pharmaceuticals
2 clinical trials · Sponsor
◉ Watch Ångstrom Pharmaceuticals
| Record | Firm | Date |
|---|---|---|
| Safety, Tolerability and Efficacy of A6 in Patients With Chronic Lymphocytic Leukemia (CLL) (NCT02046928) | Ångstrom Pharmaceuticals | 2014-02-01 |
| Efficacy of Å6 in Ovarian Cancer Patients Following First-Line Chemotherapy and a Rising CA125 Levels (NCT00083928) | Ångstrom Pharmaceuticals | 2004-05-01 |
Track Ångstrom Pharmaceuticals automatically
Every clearance here is in the API, with alerts when new ones post.